SCOPUS 정보 검색 플랫폼

Toxicon

Volumn 39, Issue 5, 2001, Pages 651-657

Anomalous enhancement of botulinum toxin type A neurotoxicity in the presence of antitoxin

(4) Sheridan, R E a Deshpande, S S a Marks, J D b Smith, T c

a US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE (United States)

b UNIVERSITY OF CALIFORNIA (United States)

c UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES (United States)

Author keywords

Antitoxin; Botulism; Monoclonal; Mouse; Toxin

Indexed keywords

ANTITOXIN; BOTULINUM TOXIN A; CELL SURFACE RECEPTOR; EPITOPE; HEMAGGLUTININ; MONOCLONAL ANTIBODY; NEUROTOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BOTULISM; CONTROLLED STUDY; DRUG ACTIVITY; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; TOXICITY TESTING;

ANIMALS; ANTIBODIES, MONOCLONAL; BOTULINUM ANTITOXIN; BOTULINUM TOXIN TYPE A; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; INJECTIONS, INTRAPERITONEAL; LETHAL DOSE 50; MALE; MICE; MUSCLE, SMOOTH; PARALYSIS;

EQUIDAE;

EID: 0035238932 PISSN: 00410101 EISSN: None Source Type: Journal
DOI: 10.1016/S0041-0101(00)00189-6 Document Type: Article

Times cited : (12)

References (13)

1
- 0030930268
- Molecular characterization of murine humoral immune response to botulinum neurotoxin type A binding domain as assessed by using phage antibody libraries
- (1997) Infect. Immunol. , vol.65 , pp. 3743-3752
- Amersdorfer, P.¹ Wong, C.² Chen, S.³ Smith, T.⁴ Deshpande, S.S.⁵ Sheridan, R.E.⁶ Finnern, R.⁷ Marks, J.D.⁸

2
- 0022556315
- Interaction of labeled botulinum neurotoxins with nerve terminals
- (1986) J. Cell Biol. , vol.103 , pp. 535-544
- Black, J.D.¹ Dolly, J.O.²

3
- 0031106637
- Efficacy of certain quinolines as pharmacological antagonists in botulinum neurotoxin poisoning
- (1997) Toxicon , vol.35 , pp. 433-445
- Deshpande, S.S.¹ Sheridan, R.E.² Adler, M.³

4
- 0030851442
- Clinical recognition and management of patients exposed to biological warfare agents
- (1997) J. Am. Med. Assoc. , vol.278 , pp. 399-411
- Franz, D.R.¹ Jahrling, P.B.² Friedlander, A.M.³ McClain, D.J.⁴ Hoover, D.L.⁵ Bryne, W.R.⁶ Pavlin, J.A.⁷ Christopher, G.W.⁸ Eitzen, E.M.⁹

5
- 0031002640
- Epitope regions in the Heavy chain of Clostridium botulinum type E neurotoxin recognized by monoclonal antibodies
- (1997) Appl. Environ. Microbiol. , vol.63 , pp. 1214-1218
- Kubota, T.¹ Watanabe, T.² Yokosawa, N.³ Tsuzuki, K.⁴ Indoh, T.⁵ Moriishi, K.⁶ Sandda, K.⁷ Maki, Y.⁸ Inoue, K.⁹ Fujii, N.¹⁰

6
- 0030694576
- Pharmacologic characterization of botulinum toxin for basic science and medicine
- (1997) Toxicon , vol.35 , pp. 1373-1412
- Pearce, L.B.¹ First, E.R.² MacCallum, R.D.³ Gupta, A.⁴

7
- 0024424934
- Inhibition of transmitter release by botulinum neurotoxin A
- (1989) Eur. J. Biochem. , vol.185 , pp. 197-203
- Poulain, B.¹ Wadsworth, J.D.F.² Maisey, E.A.³ Shone, C.C.⁴ Melling, L.⁵ Tauc, J.⁶ Dolly, J.O.⁷

8
- 0002985086
- The pharmacological mechanism of botulism
- (1985) Trends Pharmacol. Sci. , vol.6 , pp. 80-82
- Sellin, L.C.¹

9
- 0029076502
- Interactions between heavy metal chelators and botulinum neurotoxins at the mouse neuromuscular junction
- (1995) Toxicon , vol.33 , pp. 539-549
- Sheridan, R.E.¹ Deshpande, S.S.²

10
- 0030220602
- Protonophore antagonism of botulinum toxin in mouse muscle
- (1996) Toxicon , vol.34 , pp. 849-855
- Sheridan, R.E.¹

11
- 0020663105
- Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships
- (1983) J. Pharmacol. Exp. Ther. , vol.224 , pp. 135-140
- Simpson, L.L.¹ DasGupta, B.R.²

12
- 0022555430
- Molecular pharmacology of botulinum toxin and tetanus toxin
- (1986) Annu. Rev. Pharmacol. Toxicol. , vol.26 , pp. 427-453
- Simpson, L.L.¹

13
- 0027442891
- Chelation of zinc antagonizes the neuromuscular blocking properties of the seven serotypes of botulinum neurotoxin as well as tetanus toxin
- (1993) J. Pharmacol. Exp. Ther. , vol.267 , pp. 720-727
- Simpson, L.L.¹ Coffield, J.A.² Bakry, N.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.